210 related articles for article (PubMed ID: 34371246)
1. What is the optimal duration for vigabatrin monotherapy in patients with infantile spasms: 6 months or longer?
Desnous B; Lenoir M; Bitton JY; Arbour M; Villeneuve N; Whiting S; Mohammed I; Wirrell EC; Bello-Espinosa L; Ronen GM; Lortie A; Birca A
Seizure; 2021 Oct; 91():503-506. PubMed ID: 34371246
[TBL] [Abstract][Full Text] [Related]
2. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome.
Kuchenbuch M; Lo Barco T; Chemaly N; Chiron C; Nabbout R
Epilepsia; 2024 Feb; 65(2):430-444. PubMed ID: 37872396
[TBL] [Abstract][Full Text] [Related]
3. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
[TBL] [Abstract][Full Text] [Related]
4. Vigabatrin: 2008 update.
Willmore LJ; Abelson MB; Ben-Menachem E; Pellock JM; Shields WD
Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
[TBL] [Abstract][Full Text] [Related]
6. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups.
Aicardi J; Mumford JP; Dumas C; Wood S
Epilepsia; 1996 Jul; 37(7):638-42. PubMed ID: 8681895
[TBL] [Abstract][Full Text] [Related]
7. Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.
Westall CA; Wright T; Cortese F; Kumarappah A; Snead OC; Buncic JR
Neurology; 2014 Dec; 83(24):2262-8. PubMed ID: 25381295
[TBL] [Abstract][Full Text] [Related]
8. Infantile spasms in Down syndrome: good response to a short course of vigabatrin.
Nabbout R; Melki I; Gerbaka B; Dulac O; Akatcherian C
Epilepsia; 2001 Dec; 42(12):1580-3. PubMed ID: 11879370
[TBL] [Abstract][Full Text] [Related]
9. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex.
Hussain SA; Schmid E; Peters JM; Goyal M; Bebin EM; Northrup H; Sahin M; Krueger DA; Wu JY;
Epilepsy Res; 2018 Dec; 148():1-7. PubMed ID: 30296632
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin therapy in infantile spasms.
Kankirawatana P; Raksadawan N; Balangkura K
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S778-83. PubMed ID: 12403260
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of infantile spasms with vigabatrin as first-line therapy and in monotherapy: apropos of 70 infants].
Villeneuve N; Soufflet C; Plouin P; Chiron C; Dulac O
Arch Pediatr; 1998 Jul; 5(7):731-8. PubMed ID: 9759271
[TBL] [Abstract][Full Text] [Related]
12. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms.
Appleton RE; Peters AC; Mumford JP; Shaw DE
Epilepsia; 1999 Nov; 40(11):1627-33. PubMed ID: 10565592
[TBL] [Abstract][Full Text] [Related]
13. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.
Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R
Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253
[TBL] [Abstract][Full Text] [Related]
14. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
Prasad AN; Penney S; Buckley DJ
Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
[TBL] [Abstract][Full Text] [Related]
15. Epileptic spasms in tuberous sclerosis complex.
Hsieh DT; Jennesson MM; Thiele EA
Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
[TBL] [Abstract][Full Text] [Related]
16. Vigabatrin therapy implicates neocortical high frequency oscillations in an animal model of infantile spasms.
Frost JD; Le JT; Lee CL; Ballester-Rosado C; Hrachovy RA; Swann JW
Neurobiol Dis; 2015 Oct; 82():1-11. PubMed ID: 26026423
[TBL] [Abstract][Full Text] [Related]
17. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study.
Vigevano F; Cilio MR
Epilepsia; 1997 Dec; 38(12):1270-4. PubMed ID: 9578521
[TBL] [Abstract][Full Text] [Related]
18. Vigabatrin in the treatment of infantile spasms.
Koo B
Pediatr Neurol; 1999 Feb; 20(2):106-10. PubMed ID: 10082337
[TBL] [Abstract][Full Text] [Related]
19. Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis.
Biswas A; Yossofzai O; Vincent A; Go C; Widjaja E
Expert Rev Neurother; 2020 Dec; 20(12):1315-1324. PubMed ID: 33078964
[No Abstract] [Full Text] [Related]
20. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
Camposano SE; Major P; Halpern E; Thiele EA
Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
